• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sebelipase alfa for lysosomal acid lipase deficiency
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus (Afinitor® or Votubia®) in combination with exemestane in postmenopausal women with oestrogen receptor positive, HER2- negative locally advanced or metastatic breast cancer who are refractory to letrozole or anastrozole
2012     HAYES, Inc. Multiple endocrine neoplasia type 2 (MEN2)
2012     Andalusian Health Technology Assessment Area (AETSA) [Invasive telemonitoring in patients with heart failure]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Intravesical hyaluronic acid for painful bladder syndrome / interstitial cystitis]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of a program for tertiary prevention of osteoporosis in patients with hip fracture]
2012     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Practice Guideline on prevention and management of suicidal behaviour]
2012     HAYES, Inc. Custom total knee arthroplasty
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pertuzumab (Omnitarg/Perjeta®) for the first-line therapy of metastatic HER2 positive breast cancer
2012     HAYES, Inc. Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)
2012     Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Catheter-directed mechanical thrombolysis in thromboembolic disease]
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rilpivirine (Edurant®)
2012     Adelaide Health Technology Assessment (AHTA) Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome
2012     Andalusian Health Technology Assessment Area (AETSA) [Magnetic resonance guided focused ultrasound for uterine myomas ablation]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [eFlow® vibrating membrane nebulizer for the treatment of cystic fibrosis]
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rifaximin (Xifaxanta®)
2012     The Regional Health Technology Assessment Centre (HTA-centrum) [Medication reviews for patients in nursing homes. Part I: Effects on mortality and hospitalizations]
2012     Andalusian Health Technology Assessment Area (AETSA) [High-dose chemotherapy in the salvage treatment of metastatic germ cell tumours]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous tibial nerve stimulation for the treatment of overactive bladder]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment report on metal on metal hip resurfacing versus total hip replacement]
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Nevirapine (Viramune®)
2012     Health Information and Quality Authority (HIQA) Health technology assessment of a national deep brain stimulation service in Ireland
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Diagnostic agreement of digital whole slide imaging and routine light microscopy
2012     Andalusian Health Technology Assessment Area (AETSA) [Radiosurgery and stereotactic body radiation therapy. Efficacy, safety and efficiency in primary lung cancer and pulmonary oligometastases]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Sensor-augmented insulin pump for diabetic patients]
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Vitamin D supplementation in patients with active or latent tuberculosis
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Heparin-bonded vascular prostheses for the treatment of peripheral artery disease]
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Prosthetic arthroplasty in primary shoulder osteoarthritis
2012     Medical Advisory Secretariat (MAS) Specialized community-based care: an evidence-based analysis
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Biological tissue adhesive versus standard suture in conjuctival autograft for the surgical treatment of pterygium]
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Federal structures of the prevention of alcohol misuse among children and youths]
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Intraoperative cortical stimulation in brain tumor surgery
2012     NIHR Health Technology Assessment programme Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma
2012     The Regional Health Technology Assessment Centre (HTA-centrum) [Induction of labour at 41 completed until 42 completed gestational weeks, update of mini-HTA VGR 2007]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2012     The Regional Health Technology Assessment Centre (HTA-centrum) [Endovascular contra open surgical treatment of symptom generating atherosclerotic lesions of the external iliac artery]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Fostamatinib for rheumatoid arthritis – second line
2012     Institute of Health Economics (IHE) First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Timing of umbilical cord clamping for neonatal and maternal outcomes
2012     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of the immunoregulatory drugs interferon beta and glatiramer in the treatment of relapsing remitting multiple sclerosis]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for dry eye syndrome
2012     Institute of Health Economics (IHE) Bariatric treatments for adult obesity
2012     The Regional Health Technology Assessment Centre (HTA-centrum) EEG as a diagnostic tool in patients with first episode psychosis
2012     Medical Advisory Secretariat (MAS) Genetic testing for predisposition to dilated cardiomyopathy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone posterior segment drug delivery system (Ozurdex) for diabetic macular oedema– first or second line
2012     Institute of Health Economics (IHE) Insulin pump therapy for type 1 diabetes
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Psychological treatment of dental anxiety among adults
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) FDG-PET/CT for cancer staging
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ciclosporin A (Cyclokat) for keratoconjunctivitis sicca
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ponatinib for chronic myeloid leukaemia or Ph+ acute lymphoblastic leukaemia
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Botulinum toxin treatment of axillary and palmar hyperhidrosis
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) New devices for the management of glycaemia in young diabetics
2012     Medical Services Advisory Committee (MSAC) Pathology tests for latent mycobacterial infection
2012     Basque Office for Health Technology Assessment (OSTEBA) [Evaluation of the implementation of clinical guidelines in the Basque Country. Cluster randomized trial]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bitopertin for schizophrenia: primary, persistent negative symptoms; sub-optimally controlled positive symptoms – in combination with antipsychotics
2012     NIHR Horizon Scanning Centre (NIHR HSC) Liposomal cisplatin (Nanoplatin) for advanced non-small cell lung cancer – first line
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Hyperbaric oxygen therapy in the treatment of diabetic foot ulcers and late radiation tissue injuries of the pelvis
2012     NIHR Horizon Scanning Centre (NIHR HSC) BI 201335 for chronic hepatitis C infection
2012     NIHR Horizon Scanning Centre (NIHR HSC) Liposomal cisplatin (Lipoplatin) in combination with gemcitabine for pancreatic cancer – first line
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Eculizumab treatment in paroxysmal nocturnal hemoglobinuria
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab
2012     NIHR Horizon Scanning Centre (NIHR HSC) Racecadotril for acute diarrhoea: infants (older than 3 months), children and adults – add on to oral rehydration therapy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Enzalutamide for chemotherapy naive castration-resistant prostate cancer
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part V: Preterm birth]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Peginesatide for anaemia in chronic kidney disease – first and second line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trametinib in combination with dabrafenib for V600 BRAF positive advanced malignant melanoma – first line
2012     HAYES, Inc. Aquatic therapy for mobility impairment in children
2012     Medical Services Advisory Committee (MSAC) Testing for BRAF mutation in patients with metastatic melanoma for access to (1c) vemurafenib
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vemurafenib for the 1st –line unresectable stage IIIC or IV melanoma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2012     NIHR Horizon Scanning Centre (NIHR HSC) Carfilzomib (Kryprolis) for multiple myeloma – third line
2012     HAYES, Inc. Extracorporeal membrane oxygenation (ECMO) for out-of-hospital cardiac arrest in adults
2012     Medical Services Advisory Committee (MSAC) Radiofrequency ablation (RFA) for the treatment of varicose veins due to chronic venous insufficiency
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Erlotinib for the 1st -line treatment of locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) with capecitabine for advanced breast cancer
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib (Velcade) in combination with dexamethasone or pegylated liposomal doxorubicin for relapsed multiple myeloma
2012     HAYES, Inc. FlexHD acellular dermis (Musculoskeletal Transplant Foundation) for breast reconstruction
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Polylactic-glycolic acid absorbable synthetic suture (Pgla) plus antibacterial: a systematic review
2012     University of York Evidence briefing on adherence to treatment for respiratory diseases
2012     Medical Services Advisory Committee (MSAC) Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab emtansine in combination with pertuzumab for HER2-positive metastatic breast cancer – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib (Velcade) for newly diagnosed mantle cell lymphoma – first line
2012     HAYES, Inc. FlexHD acellular dermis (Musculoskeletal Transplant Foundation) for hernia repair
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Renal artery ablation in patients with treatment-resistant hypertension: a systematic review
2012     University of York Evidence briefing on drug treatments for functional class II pulmonary hypertension
2012     Medical Services Advisory Committee (MSAC) Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine
2012     The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and neck and upper extremity disorders]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab with chlorambucil for chronic lymphocytic leukaemia– first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Hybrid PET/MR systems for whole-body diagnostic imaging
2012     HAYES, Inc. Floseal hemostatic matrix (Baxter Healthcare Corp.) for hemostasis during endoscopic sinus surgery
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Fractional flow-reserve by intracoronary pressure guidewire in patients with acute coronary syndrome]
2012     University of York Evidence briefing on teleconsultation
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 status in gastric cancer for access to trastuzumab
2012     Basque Office for Health Technology Assessment (OSTEBA) [Seroprevalence of Trypanosoma Cruzi infection in Latin American women of fertile age and during pregnancy in the Autonomous Community of the Basque Country]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Generic indicators for process quality in oncological care. A compendium
2012     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for gastrointestinal stromal tumours – second line
2012     NIHR Horizon Scanning Centre (NIHR HSC) SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2012     HAYES, Inc. Floseal hemostatic matrix (Baxter Healthcare Corp.) for hemostasis during nephrectomy
2012     Medical Services Advisory Committee (MSAC) Insertion of colonic stents